丽珠医药将于8月20日举行董事会会议以审批中期业绩

Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a board meeting scheduled for August 20, 2025, to review and approve the unaudited half-year results for the six months ending June 30, 2025 [1] - The meeting will also address other matters related to the company and its subsidiaries [1]